We identified seven proteins (Amph, Dok3, Ddx17, Mbip, Rim2, Skap2, TACC3, and Usp33) that are predicted to be EGFR interaction partners and/or share interaction partners within the EGFR pathway, and three of these (Amph, Rim2, and TACC3) show increased expression levels in lung cancer (Fig. 2b and Supplementary Table 1). This evidence concerns the gene TACC3 and lung carcinoma.